Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

NEK2 Regulates Immature B Cell Development and GC Formation in NEK2 Transgenic Mouse

Wen Zhou, PhD, Xiao He, He Wang, Mohamed E Salama, M.D., Xia Jiliang, Hongwei Xu, MD, MS, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD

Blood (2012) 120 (21): 257.

https://doi.org/10.1182/blood.V120.21.257.257

Published: 2012

Journal Articles

Inhibition of RARα2 or Its Downstream Signaling Pathways Decreases Drug Resistance in Myeloma

Guido J. Tricot, MD, PhD, Ye Yang, PhD, Fang Xiao, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Fenghuang Zhan, MD, PhD

Blood (2011) 118 (21): 989.

https://doi.org/10.1182/blood.V118.21.989.989

Published: 2011

Journal Articles

ALDH1 Activity Identifies Chemotherapy-Resistant Multiple Myeloma Stem Cells

Fenghuang Zhan, MD, PhD, Wen Zhou, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Guido J. Tricot, MD, PhD

Blood (2011) 118 (21): 990.

https://doi.org/10.1182/blood.V118.21.990.990

Published: 2011

Journal Articles

High Expression of NEK2 Induces Drug Resistance by Inhibiting Premature Senescence Through Activation of the PI3K/Akt Pathway in Myeloma and Other Cancers,

Fenghuang Zhan, MD, PhD, Fang Xiao, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Guido J. Tricot, MD, PhD

Blood (2011) 118 (21): 3923.

https://doi.org/10.1182/blood.V118.21.3923.3923

Published: 2011

Journal Articles

The Effect of ICAM-1 Antibody Therapy in the SCID-Hu Mouse Model Using Primary Myeloma Cells

Guido J. Tricot, MD, PhD, Ming Zeng, Ye Yang, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Fenghuang Zhan, MD, PhD

Blood (2011) 118 (21): 2914.

https://doi.org/10.1182/blood.V118.21.2914.2914

Published: 2011

Journal Articles

CKS1B Mediates SKP2/p27Kip1-Independent Myeloma Cell Survival and Disease Progression through Activation of MEK/ERK and JAK/STAT3 Signaling Pathways.

Fenghuang Zhan, MD, PhD, Lei Shi, MD, Siqing Wang, MD, MS, Hongwei Xu, MD, Thai M. Cao, MD, Chunjiao Xu, MD, PhD, Yong Wu, MD, PhD, Maurizio Zangari, MD, Guiyuan Li, MD, PhD, Guido J. Tricot, MD, PhD

Blood (2009) 114 (22): 126.

https://doi.org/10.1182/blood.V114.22.126.126

Published: 2009

Journal Articles

Potential Eradication of Myeloma Stem Cells by Combining ATRA with WNT and HH Signaling Pathways Inhibitors.

Guido J. Tricot, MD, PhD, Siqing Wang, MD, MS, Lei Shi, MD, Hongwei Xu, MD, Chunjiao Xu, MD, PhD, Maurizio Zangari, MD, Fenghuang Zhan, MD, PhD

Blood (2009) 114 (22): 2839.

https://doi.org/10.1182/blood.V114.22.2839.2839

Published: 2009

Journal Articles

Combination of ATRA with a COX2 Inhibitor Induces Synergistic Effects On RARalpha2-Expressing Multiple Myeloma (MM) Cells.

Siqing Wang, MD, MS, Lei Shi, MD, Hongwei Xu, MD, Chunjiao Xu, MD, PhD, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD

Blood (2009) 114 (22): 2809.

https://doi.org/10.1182/blood.V114.22.2809.2809

Published: 2009

NARROW

NEK2 Regulates Immature B Cell Development and GC Formation in NEK2 Transgenic Mouse

Inhibition of RARα2 or Its Downstream Signaling Pathways Decreases Drug Resistance in Myeloma

ALDH1 Activity Identifies Chemotherapy-Resistant Multiple Myeloma Stem Cells

High Expression of NEK2 Induces Drug Resistance by Inhibiting Premature Senescence Through Activation of the PI3K/Akt Pathway in Myeloma and Other Cancers,

The Effect of ICAM-1 Antibody Therapy in the SCID-Hu Mouse Model Using Primary Myeloma Cells

CKS1B Mediates SKP2/p27Kip1-Independent Myeloma Cell Survival and Disease Progression through Activation of MEK/ERK and JAK/STAT3 Signaling Pathways.

Potential Eradication of Myeloma Stem Cells by Combining ATRA with WNT and HH Signaling Pathways Inhibitors.

Combination of ATRA with a COX2 Inhibitor Induces Synergistic Effects On RARalpha2-Expressing Multiple Myeloma (MM) Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only